additional promotional literature list dyphylline (Lufyl-lin®, Dilor® and others) as a theophylline derivative containing, or equivalent to, 70 percent theophylline. Chemically, dyphylline is the stable 7-dihydroxypropyl derivative which, in contrast to aminophylline or oxytriphylline, does not dissociate to theophylline in solution or in vivo. The figure of 70 percent represents the molecular weight ratio. For caffeine, which theoretically could be called 7-methyl theophylline, the molecular weight ratio is 90 percent; however this xanthine is never listed as a theophylline derivative.
The amount of dyphylline equivalent to a given amount of theophylline is at present unknown. Early studies on blood levels, such as those by Turner-Warwick, 1 are difficult to interpret since they were measured by the Schack and Waxier spectrophotometric assay. Both the efficiency of dyphylline extraction from organic solvent and the optimal wavelength to measure the absorbance of this compound were unknown. Even with a specific gas Chromatographie assay, 2 correlations of serum concentration, efficacy and toxicity have not been made. However, pharmacokinetic analysis of dyphylline has revealed an average half-life of 2.1 hours, 3 compared to 7 hours for theophylline. 4 With such a short half-life, it is likely that unrealistically frequent dosing would be required to maintain a serum concentration within any acceptable range.
Clinically, the efficacy of dyphylline has not been adequately evaluated. In one double-blind crossover comparison, a 1000 mg single dose of dyphylline was less effective (20 percent maximum increase in FEVj) than a 400 mg dose of theophylline (38 percent maximum increase in FEVi), although the former produced less side effects Theophylline has recently undergone extensive study with the development of rapid specific analytical methods and the definition of its therapeutic range and pharmacokinetic behavior. Dosage regimens necessary to produce therapeutic, nontoxic serum concentrations in otherwise healthy patients at various ages, 6 and in those with concurrent functional abnormalities, 7 have been reported. Comparative studies have suggested that theophylline is the most potent noncorticosteroid agent demonstrated to be effective for the suppression of chronic asthmatic symptoms. 8 Thus, it seems that the abundance of information on theophylline and the relative void of information on dyphylline make the therapeutic choice between these agents, at this time, relatively clear.
